DNER and colonic neoplasm: To identify epigenetic combinations with the potential for greater potency toward metastatic CRC, we evaluated several BET-degrader PROTACs (Figure 5A) and compared the cytotoxicity in SW480 non-metastatic vs. SW620 metastatic-lineage colon cancer cells.